GIRK Channels as Candidate Targets for the Treatment of Substance Use Disorders.

Kotajima-Murakami, Hiroko; Ide, Soichiro; Ikeda, Kazutaka

Kotajima-Murakami, Hiroko; Ide, Soichiro; Ikeda, Kazutaka.

Afiliación

Kotajima-Murakami H; Addictive Substance Project, Tokyo Metropolitan Institute of Medical Science, 2-1-6 Kamikitazawa, Setagaya-ku, Tokyo 156-8506, Japan.
Ide S; Addictive Substance Project, Tokyo Metropolitan Institute of Medical Science, 2-1-6 Kamikitazawa, Setagaya-ku, Tokyo 156-8506, Japan.
Ikeda K; Addictive Substance Project, Tokyo Metropolitan Institute of Medical Science, 2-1-6 Kamikitazawa, Setagaya-ku, Tokyo 156-8506, Japan.

Biomedicines ; 10(10)2022 Oct 13.

Article en En | MEDLINE | ID: mdl-36289814

Palabras clave

GIRK channels; alcohol; clinical trials; ifenprodil; methamphetamine; substance use disorder

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Idioma: En Revista: Biomedicines Año: 2022 Tipo del documento: Article País de afiliación: Japón Pais de publicación: Suiza

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google